🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The part B of N01362 is to assess the pharmacokinetic profile of Levetirace...
Status
Completed
Location
1
Start Date
2012-05
Trial ID
NCT01618877
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
This study is a randomized, open label, parallel group,comparing the safety...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02920060
Treatments Being Tested
Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure cont...
Status
Withdrawn
Location
Medical University of South Carolina
Start Date
2008-02
Trial ID
NCT00627133
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as tetra-O-methyl nordihydrogua...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2007-01
Trial ID
NCT00404248
Treatments Being Tested
The main purpose of this study is to see whether brivaracetam has a faster ...
Status
Completed
Location
The Comprehensive Epilepsy Care Center For Children And Adults
Start Date
2018-06-01
Trial ID
NCT03580707
Treatments Being Tested
Keppra injection is approved in the US as adjunctive therapy in the treatme...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00535392
Treatments Being Tested
The primary objective of this study is to determine the pharmacokinetic pro...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2010-09
Trial ID
NCT01239212
Treatments Being Tested
The purpose of this study is to examine the toxicity of using allogeneic st...
Status
Completed
Location
University of Louisville
Start Date
2013-04
Trial ID
NCT02472392
Treatments Being Tested